Initiative involved 2,174 doctors across India and focused on early screening and awareness around regular blood pressure monitoring 

Mumbai, August 26^th, 2026: A large-scale blood pressure (BP) screening initiative conducted by Alembic Pharmaceuticals Limited, involving 40,468 patients and 2,174 doctors across India between May 7 and May 20, has earned the company recognition in the Asia Book of Records for achieving the record of “Maximum Patients Screened for Blood Pressure in a Fortnight.”

Undertaken to encourage early screening, improve awareness of hypertension-related risks and promote regular blood pressure monitoring, the screening drive formed part of Alembic Pharmaceuticals Limited’s broader focus on cardiovascular, renal and metabolic health. These themes were further explored at the company’s Triad Symposia, Mumbai, a platform that brought together cardiologists, nephrologists, endocrinologists and physicians to discuss the evolving approach to cardiovascular, renal and metabolic health. The symposia highlighted the interconnected nature of hypertension, diabetes and early kidney disease, and the importance of early screening, risk assessment and preventive care to address disease progression and reduce the risk of cardiovascular and chronic kidney disease.

Experts highlighted the need to look at the individual as a whole rather than treating each condition in isolation. They also spoke about seeing hypertension among younger Indians, including people in their 20s and 30s, with factors such as physical inactivity, smoking, alcohol consumption, dietary habits and stress adding to the risk. The concern is compounded by the fact that hypertension can remain undiagnosed, untreated, or uncontrolled in a majority of individuals, leading to heart- and kidney-related complications if not addressed through timely intervention.

The success of the screening drive and the broader discussions around proactive healthcare were supported by the active contribution of the company’s senior leadership team, including Mr. Kunal Mukhopadhaya, Senior Vice President – CV Business; Mr. Ashish Singh Chauhan, Vice President; Dr. Sanjay Jain, Vice President Medical Team ; Mrs. Ashvini Mundhada, Deputy General Manager; Mr. Vinod Bhat, AGM, along with the entire Alembic Specia Speciality Sales & Marketing Team.

The event concluded in the presence of leading doctors, including Hon’ble Dr. Ashok Kirpalani, Dr. B. C. Kalmath, Dr. Sandip Fulpagare, Dr. Chetan Shah, Dr. Gaurav Daga, Dr. Johann Verghese, Dr. Rohit Barnabas, Dr. Manjiri Karlekar, Dr. Vikas Bharati and Dr. Nitin Sonavane, along with 65 other doctors from across Mumbai. The initiative and Alembic Pharmaceuticals Limited’s patient-first approach received widespread appreciation from the medical fraternity.

The Asia Book of Records recognition marks a significant milestone for Alembic that reflects the larger purpose behind the screening initiative. The initiative aims to make important health checks more accessible, encourage people to monitor their health and help identify risks before they become more difficult to manage.

Excessive sodium intake is a major contributor to hypertension. Although the World Health Organization recommends that adults should consume less than 5 grams of salt per day (approximately 2,000 mg of sodium), studies indicate that average daily salt intake in India ranges between 8 and 11 grams, with some recent estimates suggesting consumption is closer to 11 grams, more than double the recommended limit. The challenge lies not only in the amount of salt consumed but also in its deep-rooted role in shaping taste preferences, making it difficult for people to cut back without feeling they are compromising on flavour.

Reducing sodium intake is an important step in supporting overall health. Excess sodium consumption is linked to high blood pressure, which may increase the risk of heart disease.

Products such as Tata Salt Lite, which contain 15% less sodium compared to regular salt, can help manage daily sodium intake while maintaining taste. Lower-sodium alternatives are recommended by global health bodies like the World Health Organization (WHO), which notes that reducing sodium can contribute to better blood pressure control and lower cardiovascular risk, especially in populations with high sodium consumption.

Experts from institutions such as AIIMS have also highlighted that low-sodium salts, when used appropriately, can support heart health. However, individuals with specific medical conditions (such as kidney disease or those on certain medications) should consult a healthcare professional before making dietary changes.

Ultimately, addressing India’s growing concerns around high sodium consumption does not require extreme dietary changes. Small, consistent steps, such as choosing a lower-sodium salt variant like Tata Salt Lite, reducing intake of high-salt processed foods, and being mindful of hidden sources of sodium, can support healthier dietary habits over time. Increasing awareness and making informed choices can contribute to overall well-being as part of a balanced diet and healthy lifestyle.

Why This Simple Swap Matters

·       Making the shift to lower-sodium salt can support better dietary practices over the long term:

·       Helps manage daily sodium intake as part of a balanced diet

·       Supports maintenance of normal blood pressure when combined with a healthy lifestyle

·       Encourages mindful consumption of salt in everyday meals

·       Maintains the familiar taste of home-cooked food

Beyond switching salt, adopting simple complementary habits, such as choosing fresh foods, limiting intake of processed items, and using herbs and spices for flavour, can support healthier dietary practices as part of a balanced diet and overall lifestyle.

Concerns around high sodium intake may be multifactorial; however, informed food choices in everyday meals can contribute to improved dietary patterns over time. Making mindful choices today can support overall well-being as part of a healthy lifestyle.